BioSpace News Archive

The nation’s first African Ancestry Neuroscience Research Initiative (AANRI) announced today $2.25 million in startup funding from the investment management firm Brown Capital Management (BCM) and the State of Maryland.

TGH and USF sign founding document that will create a new organization dedicated to world-class patient care, education and research

Franco Negron Appointed as Chief Executive Officer of ApiJect Systems America and its subsidiary, RAPID USA.

As part of the Coalition Innovation Santé - Crise Sanitaire initiative, Chronolife and Servier are collaborating to accelerate the deployment of a non-invasive telemonitoring solution which aims to facilitate remote monitoring of chronic patients during the COVID-19 pandemic and enable healthcare professionals to provide better patient care.

Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in TruGenomix, a veteran-owned precision behavioral health company. As part of the strategic partnership, Sanford Health will support Tru

Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it is immediately readying testing samples of its GenViro! Covid-19 Swift Kits for testing in the US market and additional testing internationally

RAD Technology Medical Systems (RAD) is pleased to announce the completion of their most recent project, a standalone Crisis Stabilization Unit (CSU) for Palomar Health. Construction of the facility was completed in June 2020 and as of July 2, 2020 the facility was treating patients.

Alfasigma USA, Inc. today announced a strategic deal with Indegene, Inc., a global life sciences and healthcare solutions provider, to co-promote its Irritable Bowel Syndrome with Constipation (IBS-C) drug, ZELNORM ® (tegaserod), to prescribers across the United States. ZELNORM ® was approved for reintroduction by the FDA for the treatment of adult women less than 65 years of age with IBS-C in March 2019. Alfasigma acquired the brand in

MD Connected Ltd. (the Company or MD Connected), is excited to announce a new virtual care partnership with Rexall.

Humanetics Corporation (Humanetics) announced today that it has received funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to conduct a study of its drug, BIO 300, in COVID-19 patients